| MATERIALS AND METHODS
The retrospective analysis was based on the clinical data collected at Tampere University Hospital, the regional hospitals, the primary healthcare centres of Pirkanmaa Hospital District, and the occupational health care of Tampere University Hospital. In cases with unavailable patient records, the information was collected from the referral to FNA and the pathology report.
The following clinical information was collected from the patient records: the clinical problem that led to the thyroid US and FNA, the results of the TFTs made less than 3 months before the FNA; the specific findings of the US examination; and the consequences of the FNA biopsy (complications and management after the FNA).
Three to five passes are usually performed per nodule on US-guided FNA. All the FNA samples were alcohol-fixed, cytospun and Papanicolaou stained. All the FNAs were analysed according to the BSRTC.
If more than one nodule was sampled by FNA in the same examination, the more severe Bethesda finding was included in the analyses.
An experienced thyroid pathologist (I.K.) re-evaluated 20% (n = 73) of the FNA samples, blinded to the results of the previous examination. The goal was to guarantee high quality categorisation during the first year of implementation of the BSRTC. If the management after the FNA was surgical, the final histopathological diagnosis was also reviewed. The FNA-targeted nodule was identified during T A B L E 1 Description of the study cohort (n = 363) subjected to thyroid FNA In 74 cases (20%), the indication for thyroid US was other than a palpable or an incidentally found nodule or a goitre (eg. hypothyroidism, complaints of compression, pain or swelling in the neck).
The frequency of the cytological diagnoses is shown in Table 2 .
One third (126, 35%) of the samples belonged to a BSRTC group for which repeat FNA is recommended; 94 (26%) samples were nondiagnostic, and 32 (9%) were classified into the AUS/FLUS category.
One third of the samples classified as non-diagnostic contained cyst fluid only.
The cytological findings differed between male and female patients, with benign findings being more frequent in the females (Table 3) (Table 3) .
A repeat FNA was performed on 23 (24%) of the patients with a non-diagnostic finding and on 18 (56%) of those with an AUS/FLUS finding ( In the quality control analysis (Table 5) , 73 (20%) of the FNA samples were re-evaluated by an experienced thyroid pathologist.
The diagnostic category changed on re-evaluation in 10 (14%) of the samples. Most of these samples changed from the benign to the non-diagnostic category. The interobserver agreement was 86%.
A total of 78 (22%) patients in the study population underwent thyroid surgery (Table 6 ), either a lobectomy or a total thyroidectomy. Of the operated cases, 27 (35%) were malignant tumours, and in 51 (65%) the final histopathological diagnosis was AUS/FLUS, atypia of undetermined significance/follicular lesion of undetermined significance.
Of the patients whose indication for thyroid US was other than a palpable or an incidentally found nodule, 30 were operated on.
The final histopathological diagnosis was papillary carcinoma in eight patients (27%). All these patients with a malignant histopathological finding had neck or throat symptoms, and a visible nodule in the US examination. When the final histopathological diagnosis was Hashimoto's thyroiditis (n = 7), the indication for US was other than a nodule in every patient.
Of the patients with an AUS/FLUS finding, seven (22%) were referred straight to a diagnostic lobectomy ( Table 4 ). The final histopathological diagnosis was goitre in four, Hashimoto's thyroiditis in two and follicular adenoma in one of the cases. Twenty-two (73%) of the patients with a follicular neoplasm cytology were referred to a diagnostic lobectomy (Table 4) . Among these patients the histopathological diagnoses were goitre in four, follicular adenoma in 15, follicular carcinoma in two and Hashimoto's thyroiditis in one of the cases.
| DISCUSSION
The present study showed a high sensitivity and specificity of the formed. 16 The high malignancy rate (33%) among the non-diagnostic samples of this cohort is likely to result from a random effect, as only three non-diagnostic samples were referred to surgery and histopathological analysis. In the present cohort, 2% of the FNA samples fell into the malignant category. All the tumours classified as malignant on FNA and subsequently operated on, were papillary carcinomas in the histological analysis. In addition, the histological analysis verified five follicular carcinomas, the BSRTC categories of which were follicular neoplasia in three, suspicious for malignancy in one and non-diagnostic in one of the cases. Of the cases classified as suspicious for malignancy, 90% were referred for thyroid surgery, and their malignancy rate was 71%. These results correlate well with the meta-analysis of Bongiovanni et al, 11 and confirm the high reliability of the BSRTC right from the start of its application at the pathology unit analysing all the samples of the present study.
The aim of a FNA biopsy is to verify the nature of a thyroid nodule, and to help selecting the ones that need operative treatment. In this study, the overall malignancy rate of the operated cases (35%) was similar to the average rate in previous studies (33.8%), 11 and the rate of neoplasia (either benign or malignant) was 62%. In 33% of the operated cases, the recommended management according to the BSRTC category was not surgical. The most common reasons for surgery in these cases were a refilling cyst or a large goitre, causing discomfort in the neck.
Currently, follicular neoplasms are treated operatively, as benign and malignant follicular lesions cannot be differentiated on cytological examination. The risk of neoplasia has been included in the latest analyses of thyroid cytology, to highlight the fact that also adenomas should often be surgically removed, but the rate of neoplasia is still rarely reported in literature. In the study of Dincer et al, 17 the rate of neoplasia in the AUS/FLUS category was 34%, which is comparable with our results (27%). 14, 17 The development of molecular testing might help in avoiding unnecessary thyroidectomies in patients with indeterminate thyroid nodules. 6, [18] [19] [20] More data are needed to evaluate the clinical applicability of the evolving molecular diagnostics. 6, 21 In conclusion, the clinical judgement of the indications of thyroid US and FNA, and the proper management according to the FNA findings could be further improved, to target the invasive investigations and treatment to patients likely to benefit from them. When properly used, the Bethesda system is sensitive and specific, and useful in avoiding unnecessary surgery.
ACKNOWLEDG MENTS
We thank Dr Ritva Kannisto for her help in the acquisition of the clinical data, and Esko V€ ayrynen, MA, for revising the language of the manuscript. This work was supported by grants from the Competitive Research Funding of the Pirkanmaa Hospital District.
CONFLI CT OF INTEREST
The authors have nothing to disclose.
O R C I D
I. Kholov a http://orcid.org/0000-0003-4089-0450
